SCIP

NOVEMBER 17, 2024

Generative AI in Healthcare and Biotech In healthcare and biotechnology, GenAI is advancing drug discovery, diagnostics, and personalized medicine. By simulating various design scenarios, GenAI accelerates the time it takes to bring new products to market, giving companies a competitive edge.

SCIP 40

SCIP Biotech Finance Innovation 40

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

MARCH 26, 2025

The IPO proceeds will go toward new production and research facilities worldwide, as well as expanding and upgrading existing factories in China. Hengrui has transitioned from a generic drug manufacturer to a major player in oncology, immunotherapy, and innovative treatments, investing heavily in global R&D infrastructure.

Commerce 59

Commerce Pharmaceutical Capital Biotech 59

Alpha Sense BI

AUGUST 30, 2023

Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market.

Management 98

Management Biotech Due Diligence Algorithm 98

BIS Research

MARCH 19, 2019

This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.

Globalization 64

Globalization Biotech Marketing Marketing 64

Alpha Sense BI

MAY 28, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services— ushered in funding rounds over $100 million since the beginning of the year. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?

Capital 69

Capital Startups Biotech Due Diligence 69

ArchIntel

JUNE 9, 2021

Earlier in his career, Fields worked as a conference and marketing coordinator at EBD Group, an organizer of biotech and medical device events. Fields briefly served as a consultant for the UCLA Anderson School of Management while already employed at the telco.

Competitive 104

Competitive Competitive Intelligence Biotech Profiling 104

Sedulo

MARCH 15, 2023

By leveraging our proprietary approach to research and insight development, our skilled team of competitive strategy professionals follows a systematic “Four I’s” process to gather Information, analyze Intelligence, uncover Insights, and contextualize Implications. Assess and benchmark enrollment timing.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Fuld

NOVEMBER 1, 2022

BOSTON – Nov 1, 2022 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Brad Thompson to the role of Advisory Board Member. Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Owler

JUNE 14, 2023

In Series A Funding Italy-based biotech company Aavantgarde Bio expressed that its initial focus following its successful funding round is to utilize the $65.3M In Series A Funding Italy-based biotech company Aavantgarde Bio expressed that its initial focus following its successful funding round is to utilize the $65.3M

Biotech 52

Biotech Startups Capital Research 52

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

APRIL 29, 2024

This staggering statistic is representative of a transformative shift in the asset management space away from archaic research methods. Generative AI in venture capital streamlines workflows, reduces research and due diligence blind spots, and surfaces qualitative and quantitative insights to make data-driven decisions faster.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

APRIL 19, 2024

Spatial Computing is Poised for Growth A relatively new concept, spatial computing is defined as “human interaction with a machine in which the machine retains and manipulates referents to real objects and spaces,” according to MIT Media Lab researcher Simon Greenwold. billion by 2030 with a CAGR of 23.1%

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. Below are the quintessential MI resources for staying ahead of the competition in today’s market.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. Soft Data – Investment researchers often use soft market data to add qualitative context to numerical data and create a comprehensive view of any research topic.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Alpha Sense BI

JUNE 6, 2024

We expand on these features in greater detail below: Semantic Search With our AI search technology, you no longer have to manually CTRL-F through fragmented research documents and reports. This means you can shave hours of time off your research and be more confident in the accuracy and comprehensiveness of your results.

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. while completing his postdoctoral research work with the University of California. He holds B.A.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

NOVEMBER 9, 2022

M&A IPOs to watch in Pharma and Biotech. Annaliesa Anderson, Senior VP and Chief Scientific Officer for Bacterial Vaccines – Vaccine Research & Development Unit. Zaslav, President, CEO & Director. JOYY Inc. [YY]. Earnings: Estimated Thu Nov 10, 2022. Scroll back to top. Exclusive Webcast. Life Sciences.

Sales 52

Sales Loss Capital Biotech 52

CIO

JULY 17, 2023

But among those who are, most engage in such work in a limited fashion, according to research on the role. CIOs will have an explicit role in creating business value,” says Bobby Cameron, vice president and principal analyst at research firm Forrester. Granted, many CIOs are already involved in these endeavors to varying degrees.

Biotech 370

Biotech Innovation Research Technology 370

CIO

MARCH 4, 2025

As a business executive who has led ventures in areas such as space technology or data security and helped bridge research and industry, Ive seen first-hand how rapidly deep tech is moving from the lab into the heart of business strategy. For example, generative AI went from research milestone to widespread business adoption in barely a year.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

MARCH 4, 2024

Evolve your primary market research across the healthcare sector when you start your free trial with AlphaSense today. What I’m just starting to see is that people are leaving the pharma companies and joining these [AI tools provider] companies.

Biotech 52

Biotech Pharmaceutical Intelligence Intelligence 52

Alpha Sense BI

MARCH 28, 2023

These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring. Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach.

Value Chain 52

Value Chain Biotech Research Competitive 52

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. Streamline your research workflow, gain the competitive edge, and uncover new opportunities with AlphaSense.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 14, 2025

Biotech Funding Healthcare and biotech have experienced ongoing funding dryspells, with public funding down 56% for biotechnology companies in January of this year. However, according to broker research from the AlphaSense platform, robust VC funding helped offset an otherwise down month for biotech funding.

Capital 59

Capital Biotech Startups Finance 59

ATTEST

NOVEMBER 22, 2024

Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. But with so many options for market research, from traditional focus group facilities to modern research platforms, finding the right partner isn’t always straightforward.

Market Research 52

Market Research Marketing Research Research Marketing 52

ATTEST

DECEMBER 20, 2024

From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. The city has some well-establised traditional local agencies and modern research companies, each with their own expertise. Attest approaches market research differently.

Market Research 52

Market Research Marketing Research Research Marketing 52

Alpha Sense BI

FEBRUARY 6, 2025

Leading broker research in the AlphaSense platform referred to it as the biggest software deal of 2024. Billion (Closed in May 2024) This deal is an important one for the biotech sector, as it significantly expands Vertexs reach beyond their current focus on cystic fibrosis treatments into the market for kidney disease therapies.

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Alpha Sense BI

APRIL 3, 2025

Concurrently, smaller biotech firms and midsized companies offering promising innovations, particularly in high-demand therapeutic areas such as oncology, immunology, neuroscience, and cardio-metabolic conditions, are expected to become highly attractive targets. How will tariff policies play out?

Biotech 52

Biotech Pharmaceutical Loss Research 52

Happy Market

MAY 9, 2022

Founded in 2007, Civic Science is a consumer intelligence research platform that polls millions of Americans each week covering thousands of topics. HubUX is a research operation platform for private panel management, qualitative automation including video audition questions, and surveys. Happy Researching! ??. [00:00:00].

Management 52

Management Entertainment Market Research Marketing Research 52

Alpha Sense BI

JANUARY 8, 2025

In this blog, we leverage proprietary expert interviews from the AlphaSense market research platform to understand the top trends shaping the healthcare landscape in 2025. Director with a large managed care organization Biotech and Pharma The Trump administration is expected to bring a relaxation of antitrust enforcement. Kennedy Jr.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69